Pork chops are on display at a Sam's Club, Wednesday, Sept. 24, 2025, in Bentonville, Ark.
A growing coalition of farm and environmental groups is urging Health Canada to require clear labels on pork from gene-edited pigs, arguing that transparency is essential as the technology moves closer to Canadian grocery shelves. Their call follows the federal agency’s recent approval of gene-edited pigs designed to resist a costly livestock disease, a decision that has reignited debate over consumer choice and public trust.
Health Canada approved the sale of pork from pigs engineered to resist Porcine Reproductive and Respiratory Syndrome Virus, commonly known as PRRSV. The illness can devastate herds, leading to severe respiratory issues, reproductive failure, and significant financial losses for farmers. By removing a small portion of a gene that makes pigs vulnerable to the virus, scientists have created animals that can withstand infection without altering their nutritional profile, according to the regulator.
In its assessment released earlier this year, Health Canada concluded the PRRSV-resistant pigs pose no greater risk to human health than conventional pigs. The agency also stated there are no nutritional differences between meat from gene-edited pigs and traditional pork. Because no safety concerns were identified, officials determined that special labelling is not required.
Transparency at the Heart of the Debate
For advocacy groups such as the Canadian Biotechnology Action Network, the absence of mandatory labelling is precisely the problem. Lucy Sharratt, the organization’s coordinator, argues that if gene-edited pork enters the market without labels, consumers will have no way of knowing what they are purchasing.
She points to public opinion surveys suggesting that more than 80 percent of Canadians want genetically engineered foods clearly identified. Although Canadian regulations do not require mandatory labels for genetically engineered foods, a voluntary standard has existed for companies choosing to disclose such information. That framework, however, faces uncertainty as the Canadian General Standards Board, which oversees the voluntary standard, is set to close at the end of March.
In a recent letter to federal Health Minister Marjorie Michel, the coalition described mandatory labelling as essential. The groups contend that approving gene-edited pigs could open the door to other gene-edited foods, making consistent labelling policies even more important.
Industry Concerns and Export Realities
The debate has also reached the farming community. René Roy, chair of the Canadian Pork Council and a Quebec-based producer, says he doubts consumers are ready to accept genetically engineered pork. Reflecting those concerns, he does not plan to breed PRRSV-resistant pigs on his own farm.
Other producers worry that without mandatory labels, companies avoiding gene-editing technology may shoulder additional costs to prove their products are not genetically modified. Vincent Breton, president of Quebec-based duBreton, which holds organic and animal welfare certifications in Canada and the United States, says voluntary labelling could shift the burden unfairly. If disclosure is optional, he argues, producers who reject gene-editing may have to invest more heavily to demonstrate that choice to consumers.
Still, neither Breton nor Sharratt opposes the technology outright. Their primary concern centers on preserving informed choice and maintaining public confidence in Canada’s food system.
Health Canada Defends Its Process
Health Canada maintains that its review process reflects more than two decades of scientific evaluation, developed in consultation with international bodies such as the World Health Organization and the Food and Agriculture Organization of the United Nations. The agency assessed data submitted by Genus PLC, the company behind the PRRSV-resistant pigs, and says its scientists conducted thorough analyses to validate the findings.
Critics, however, question the transparency of that process, noting that detailed data from company submissions are not publicly released. They argue that openness is crucial to strengthening trust, especially as gene-editing technologies evolve.
Although Genus PLC has also received authorization in several other countries, the company has indicated it does not intend to sell the pigs before securing approval in key export markets. That consideration is significant for Canada, which exports roughly 70 percent of its pork production, valued at billions annually.
For now, Health Canada emphasizes that even with regulatory approval in place, the decision to use PRRSV-resistant pigs will rest with individual producers. Yet as the technology advances, the broader question of labelling may determine not just how pork is marketed, but how confident Canadians feel about what lands on their plates.
